Prellis Biologics Patents

Patent portfolio assigned to Prellis Biologics (verified via public assignee records). 3D-bioprinting / EXIS externalized-human-immune-system antibody discovery (San Francisco). Drug-discovery collaborations/license agreements with Eli Lilly, Bristol Myers Squibb and Sanofi confirmed via press releases. Multiple patents assigned to Prellis Biologics, Inc. on Google Patents (e.g. US10513691B2, US10933579B2, US20190010463A1) - exact count not enumerated.